We are delighted to introduce our new CEO, Katie Endacott and to share a statement from Vicky Pleydell, Chair of Trustees: "I am delighted to …
Introducing Action Duchenne’s new CEO: Katie EndacottRead More
November 5, 2025 by Lizzie Cox
We are delighted to introduce our new CEO, Katie Endacott and to share a statement from Vicky Pleydell, Chair of Trustees: "I am delighted to …
Introducing Action Duchenne’s new CEO: Katie EndacottRead More
November 3, 2025 by Lizzie Cox
We're Hiring: Outreach Support Officer (Scotland) Job Role: Outreach Support Officer (Scotland), Full Time Responsible to: Support Team …
We are recruiting: Outreach Support Officer (Scotland)Read More

October 23, 2025 by Lizzie Cox
Action Duchenne comment on statement from NorthStar Network UK about Givinostat Firstly, and most importantly, our thoughts are with the families of …
Action Duchenne comment on statement from NorthStar Network UK about GivinostatRead More

October 21, 2025 by Lizzie Cox
Community Accessibility and Support Our Community Accessibility and Support stream will run on Friday 14th November. It's designed to equip and …
September 10, 2025 by John Marrin
This month there will be an opportunity for everyone interested in learning more about nutrition and Duchenne to participate in two online focus group …
DMD Care UK Nutrition Working Group – Online Focus GroupsRead More
September 8, 2025 by Lizzie Cox
Urgent action needed to protect families affected by Duchenne muscular dystrophy I am deeply concerned about the devastating impact the collapse of …
September 6, 2025 by Lizzie Cox
Family: The Heart of Care September 7th marks World Duchenne Awareness Day. The 7th day of the 9th month in honour of the 79 exons on the …
August 22, 2025 by Mehreen Arif
On July 25th, Roche 5 the European Medicines Agency’s (EMA's) Committee for Human Medicinal Products (CHMP) unfortunately provided a negative opinion …
Update from Roche regarding Delandistrogene Moxeparvovec (Elevidys)Read More

August 15, 2025 by Katie Endacott
On July 29th, Roche announced its readiness to immediately resume new orders and shipments of Elevidys for ambulatory patients outside the United …
Roche to resume Elevidys orders for ambulatory patients outside of the US Read More

August 7, 2025 by John Marrin
Entrada Therapeutics has released its financial results for the second quarter of 2025, which included important updates on its clinical programs for …
Entrada Therapeutics Shares Update on Duchenne Muscular Dystrophy (DMD) ProgramsRead More
July 25, 2025 by Lizzie Cox
Join us this World Duchenne Awareness Day This year the theme for World Duchenne Awareness Day is “Family: The Heart Of Care”. This theme …

July 23, 2025 by John Marrin
Today (23rd of July), Roche issued a community update regarding its Duchenne program, specifically addressing the availability of delandistrogene …
Action Duchenne
5th Floor, Mariner House
62 Prince Street
Bristol
BS1 4QD
07535 498 506
info@actionduchenne.org
